Embed Size (px)
DESCRIPTION
For the complete report, get in touch with us at : [email protected] Futura Surgicare Pvt. Ltd. is headquartered in Bangalore and manufactures Medical Equipments in the domains of PETCRYL 910 - Polyglactin 910 Sutures, PETCRYL - Polyglycolic Acid Sutures, etc. The report begins with the basic facts about the company such as contact details, revenues, competitors, brief history, line of business and geographic reach among others. Key Products and Services of the company describes the rationale of how it creates, delivers, and captures value through its products and services offered Information about the company’s management side is also provided that details their names, designation, professional experiences, memberships of boards etc. Through SWOT analysis, the report highlights key internal factors that give the company advantage or disadvantage over its peers along with key external factors prevailing in the industry that may have favorable or unfavorable impact on the company’s operations. The report also covers the financial analysis of the company including the balance sheet, profit and loss a/c and the key ratios depicting the key financial figures for fiscal year 2008-11. Industry Analysis provides top level understanding of the Medical Equipment sector in India with special reference to Surgical Instruments segment. Market size, growth, key segments, growth drivers, import \ export and trends are some of the foremost points covered in the analysis. The competitive landscape identifies key players of the industry drawing comparisons on parameters such financial performance and service offerings. The company is benchmarked against its main competitors’ key financial ratios in the competitive benchmarking chapter.
Citation preview
Futura Surgicare Pvt. Ltd. February 2012
2
Contents
Executive Summary
Factsheet
Offices & Centres
Key Products and Services
Key People
SWOT Analysis
Financial Profile
Industry Analysis
Competitive Landscape
Competitive Benchmarking
Appendix
Futura Surgicare Pvt. Ltd.
3
Executive Summary
Company Description
• Futura Surgicare Pvt. Ltd. is headquartered in A and manufactures B and C
• It has clients in D, E, F, G, H, etc.
Key Products and Services
• It manufactures surgical equipments such as A, B, C, D, E, etc.
SWOT Analysis
• Strength 1 is one of the major strengths of the company; however weakness 1 is one of the key areas of concern
• The company can reap significant benefits owing to opportunity 1 while threat 1 may have an adverse affect on the strategic initiatives and growth prospects of the organization
Financial Profile
• Futura Surgicare Pvt. Ltd. generated total revenues of INR A mn in the fiscal year (FY) 20‐‐ registering a y‐o‐y increase of x per cent. It earned a net profit of INR B mn in FY 20‐‐ as compared to a net profit of INR C mn in FY 20‐‐
• The financial profile of the company includes the balance sheet, profit and loss a/c and the key ratios depicting the key financial figures for FY 20‐‐, 20‐‐, 20‐‐ and 20‐‐, giving an insight into the company's financial performance
Industry Analysis
• Medical Equipments market is estimated at INR A bn in FY 20‐‐ and expected to grow at a CAGR of x per cent to reach INR B bn in FY 20‐‐
• The Medical Equipments market is classified into segments such as P, Q, R and S
• The Surgical Instruments market in India is estimated at INR A bn in FY 20‐‐ and is expected to grow at a CAGR of x per cent to reach INR B bn by FY 20‐‐
• The key drivers are A, B, C and D
Competitive Landscape
• Key competitors for the company can be enlisted as: Competitor 1 and Competitor 2
4
SAMPLE
FactsheetBasic Information
• Futura Surgicare Pvt. Ltd. (Futura) is headquartered in A and manufactures B and C
‐‐
‐‐
‐‐
‐‐
‐‐
‐‐
• Futura offers B under the brand name J, K under the brand name of N and C under the brand name Z
• It is the first company to introduce the T in India
• The company manufactures products such as P, Q, R, S, etc.
• It has clients in D, H, Y, U, P, etc.
Brief Description
‐‐Auditor
Industry ‐‐
Corporate Address ‐‐
Tel No. ‐‐
Fax No. ‐‐
Website ‐‐
Year Founded ‐‐
Year of Incorporation ‐‐
Ownership ‐‐
Revenue ‐‐
Fiscal Year End ‐‐
Key Competitors ‐‐
Source:
Brief History
• 19‐‐:
5
Offices & Centres – India (1/3)
Note:Source:
SAMPLE
Headquarters
6
Offices & Centres – Global (2/3)
Export Countries (Futura)
Source: Note:
Thailand
SAMPLE
7
`
• F
• I
• H
• G
PRODUCTS
• E
• D
• C
• B
• A
• J
Key Products and Services
Source:
The company generates revenue through its products which include :
SAMPLE
8
Key PeopleKey People Ownership Structure
Source:
Shareholding Pattern
Total Paid‐up Capital INR A
Total Number of shareholders ‐
Name DesignationAge
(Years)Date of
Appointment
‐‐ ‐‐ ‐‐ ‐‐
‐‐ ‐‐ ‐‐ ‐‐
‐‐ ‐‐ ‐‐ ‐‐
Note:
x%
T
Shareholders of the Company
‐‐‐‐
Name No. of Shares Held
‐‐ ‐‐
‐‐ ‐‐
‐‐ ‐‐
SAMPLE
9
SWOT Analysis (1/2)
Source:
Internal Factors
• Strength 1
• Strength 2
•Weakness 1
Strengths Weakness
SAMPLE
10
SWOT Analysis (2/2)
Source:
External Factors
• Opportunity 1
• Opportunity 2
• Threat 1
• Threat 2
Opportunities Threats
SAMPLE
11
SAMPLE
Financial Profile
Particulars 2008 2009 2010 2011
Operating Income
‐ ‐ ‐ ‐
Total Income ‐ ‐ ‐ ‐
Expenditure (below)
‐ ‐ ‐ ‐
Operating expenses
‐ ‐ ‐ ‐
Total Expenditure
‐ ‐ ‐ ‐
Profit/(Loss) before Tax
‐ ‐ ‐ ‐
Profit/(Loss) after Tax
‐ ‐ ‐ ‐
0
20
40
60
80
100
120
INR mn
20‐‐
W
V
20‐‐
U
T
20‐‐
S
R
20‐‐
Q
P
Financial Snapshot Profit & Loss Statement
Note:
Financial Summary
Net Profit/Loss after tax
Total Income
• Analysis Point 1
• Analysis Point 2
• Analysis Point 3
Source:
12
SAMPLE
Ratio AnalysisKey Ratios
Source:Note:
Key Ratio Analysis
Improved Decline
Particulars y‐o‐y change
(2011‐10)2011 2010 2009 2008
Profitability Ratios ‐ ‐ ‐ ‐ ‐
Operating Margin ‐ ‐ ‐ ‐ ‐Net Margin ‐ ‐ ‐ ‐ ‐Profit Before Tax Margin ‐ ‐ ‐ ‐ ‐Return on Equity ‐ ‐ ‐ ‐ ‐Return on Capital Employed ‐ ‐ ‐ ‐ ‐Return on Working Capital ‐ ‐ ‐ ‐ ‐Return on Assets ‐ ‐ ‐ ‐ ‐Return on Fixed Assets ‐ ‐ ‐ ‐ ‐
Cost Ratios ‐ ‐ ‐ ‐ ‐Operating costs (% of Sales) ‐ ‐ ‐ ‐ ‐
Liquidity Ratios ‐ ‐ ‐ ‐ ‐
Current Ratio ‐ ‐ ‐ ‐ ‐Cash Ratio ‐ ‐ ‐ ‐ ‐
Leverage Ratios ‐ ‐ ‐ ‐ ‐
Debt to Equity Ratio ‐ ‐ ‐ ‐ ‐Debt to Capital Ratio ‐ ‐ ‐ ‐ ‐
Efficiency Ratios ‐ ‐ ‐ ‐ ‐
Fixed Asset Turnover ‐ ‐ ‐ ‐ ‐Asset Turnover ‐ ‐ ‐ ‐ ‐Current Asset Turnover ‐ ‐ ‐ ‐ ‐Working Capital Turnover ‐ ‐ ‐ ‐ ‐Capital Employed Turnover ‐ ‐ ‐ ‐ ‐
• Analysis point 1
• Analysis point 2
• Analysis point 3
• Analysis point 4
• Analysis point 5
• Analysis point 6
• Analysis point 7
13
SAMPLE
Annual Financial Ratios
0
5
10
15
20
25
30
35
2008 2009 2010 2011
0
5
10
15
20
25
30
35
2008 2009 2010 2011
Profitability Ratios
0
10
20
30
40
50
2008 2009 2010 2011
0
50
100
150
200
2008 2009 2010 2011Source:
14
SAMPLE
Industry AnalysisMedical Equipment Industry – Overview • The Medical Equipment market is estimated at INR A bn in FY 20‐‐ and expected to grow at a CAGR of x per cent to reach INR B bn by FY 20‐‐
• This market can be classified into segments such as C, D, E and F
• Indian medical equipment market imports y per cent of its medical equipments from countries such as M, N, O, P
• Major trends observed in the medical equipment market are: Trend 1
Trend 2
Trend 3
Trend 4
Trend 5
• Some of the key drivers of the medical equipment market are: Driver 1
Driver 2
Driver 3
Driver 4
Driver 5
• Some of the Government initiatives towards the Medical equipment market were: Point 1
Point 2
0
20
40
60
80
100
INR bn
x%
20‐‐e
G
20‐‐e
F
20‐‐e
E
20‐‐e
D
20‐‐e
C
20‐‐
B
20‐‐
A
Market Size & Growth (20‐‐ ‐20‐‐e)
Market Segmentation (FY 20‐‐)
a%
d%
c% b% PONM
Source:
15
SAMPLE
Industry AnalysisSurgical Instruments Market – Overview Market Size & Growth (20‐‐ ‐20‐‐e)
Source:
Import ‐ Export Pattern of Major Surgical Instruments
• The Surgical Instruments market in India is estimated at INR A bn
in FY 20‐‐ and is expected to grow at a CAGR of x per cent to
reach INR B bn by FY 20—
• Surgical Instruments is a part of the X
• Some of the key drivers of the surgical instruments market are:
‐‐
‐‐
‐‐
‐‐
• Some of the major trends are:
A
B
C
49%12%
0
5
10
15
20
25
20‐‐
Q
20‐‐
P
INR bn
R
x%
20‐‐e
U
20‐‐e
T
20‐‐e
S
20‐‐e
0
1,000
2,000
3,000 F
E
20-- 20--
HINR mn
G
20--
D
C
20--
BA
ExportsImports
‐‐‐‐
‐‐‐‐
‐‐‐‐
‐‐‐‐
‐‐‐‐
‐‐
HS Code Description
‐‐
HS Code
16
Competitive Landscape (1/2)
Company Name Description
Company 1 ‐‐
‐‐
‐‐
‐‐
Company 2 ‐‐
‐‐
‐‐
‐‐
Source:
SAMPLE
17
Competitive Landscape (2/2)Competitive Scenario
Company Name Company A Company B Company C
Financial Information (INR mn – FY 2010)
Total Revenue ‐‐ ‐‐ ‐‐
Net Profit/(loss) ‐‐ ‐‐ ‐‐
Major Market Segmentation (Medical Equipments)
Surgical Instruments
Sutures \Suture Needles
Cannulas
Forceps
Scissors
Retractors
Catheters
Blades
Knives
Scalpel
Offered Not OfferedSource:
H: High; L: Low; M: Medium
SAMPLE
18
SAMPLE
Competitive Benchmarking (1/2)
0
10
20
30
40
%
V
FE
U
DC
T
B
A
NM
0
20
40
60
K
U
JI
T
H
G
V
L
% GF
0
50
100
%
V
O
U
N
T
M
P
• Analysis Point 7
• Analysis Point 4
• Analysis Point 5
• Analysis Point 6
• Analysis Point 1
• Analysis Point 2
• Analysis Point 3
Key Financial Ratios – FY 2010 (1/2)
Source:
19
Thank you for the attention
www.netscribes.com
About NetscribesNetscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and growth objectives.
Futura Surgicare Pvt. Ltd. is a part of Netscribes’ Healthcare Company Profile Series. For more detailed information or customized research requirements please contact:
This report is published for general information only. Although high standards have been used in preparing this report, Netscribes (India) Pvt. Ltd. or Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes (India) Pvt. Ltd. and no part may be reproduced without prior written permission.
Jitendra PunjabiPhone: +91 33 4064 6215E‐Mail: [email protected]
